1. Home
  2. GEOS vs BOLD Comparison

GEOS vs BOLD Comparison

Compare GEOS & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geospace Technologies Corporation (Texas)

GEOS

Geospace Technologies Corporation (Texas)

N/A

Current Price

$3.79

Market Cap

61.4M

Sector

Industrials

ML Signal

N/A

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

N/A

Current Price

$2.48

Market Cap

54.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
GEOS
BOLD
Founded
1980
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
54.5M
IPO Year
1997
2024

Fundamental Metrics

Financial Performance
Metric
GEOS
BOLD
Price
$3.79
$2.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
83.9K
★ 162.0K
Earning Date
11-19-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.47
EPS
N/A
★ N/A
Revenue
★ $110,803,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.92
$0.96
52 Week High
$28.77
$3.16

Technical Indicators

Market Signals
Indicator
GEOS
BOLD
Relative Strength Index (RSI) 31.95 46.97
Support Level N/A $2.37
Resistance Level $4.80 $2.65
Average True Range (ATR) 0.24 0.11
MACD -0.05 0.01
Stochastic Oscillator 19.95 44.44

Price Performance

Historical Comparison
GEOS
BOLD

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: